Posts by: Maureen Newman

Maureen Newman

Maureen Newman is a science columnist for Pulmonary Hypertension News. She is currently a PhD student studying biomedical engineering at University of Rochester, working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit's laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment.

December 15, 2015December 15, 2015

StemGenex’s New Rheumatoid Arthritis Clinical Study of Stem Cell Therapy Enrolling

rheumatoid arthritis

RA patients are enrolling in a clinical study from StemGenex that looks to harness the power of patient-specific, adipose-derived mesenchymal stem cells (MSCs) for their anti-inflammatory and potentially therapeutic properties. ... Read more

August 19, 2015August 19, 2015

Statin Associated with Lower Mortality in RA Patients

News, rheumatoid arthritis

One of the benefits of large medical record databases is the availability of a vast amount of information related to medication use and patient health status. For example, a research ... Read more

August 14, 2015August 14, 2015

Disease-Modifying Antirheumatic Drug-Free Sustained Remission Increased Over The Last Decade

News, rheumatoid arthritis

As science and medicine evolve over time, rheumatoid arthritis (RA) patients are experiencing an increase in quality of life from improved disease prognosis. In large part, advances in treatment strategies ... Read more

July 13, 2015July 13, 2015

Less-Intense Rituximab Treatment is Cost-Effective

News, rheumatoid arthritis

Rituximab was shown to be a cost-effective second-line treatment for individuals with rheumatoid arthritis in a recent article from University Hospital Santa Maria della Misericordia in Italy. A team from ... Read more

July 1, 2015July 8, 2015

Study Suggests Inflammation Must Be Considered to Predict Mortality

News, rheumatoid arthritis

When patients with rheumatoid arthritis want to know their mortality risk, their clinicians must rely on models generated in studies that consider a wide range of risk factors. These models ... Read more

June 11, 2015June 12, 2015

Biogen and Samsung Bioepis Develop Biosimilars for RA Treatment

News, rheumatoid arthritis

Biogen and Samsung Bioepis Co., Ltd. have three exciting new anti-tumor necrosis factor (anti-TNF) biosimilars under development to treat patients with rheumatoid arthritis. Representatives from the companies will present data at ... Read more

April 30, 2015April 30, 2015

Genetic Haplotypes Correlate with RA Severity, According To Study

News, rheumatoid arthritis

Knowing if you will be affected by severe rheumatoid arthritis even before you attempt treatment may be possible using the results of a study conducted at University of Manchester. Lead ... Read more

April 24, 2015April 24, 2015

Researchers Say Understanding Immune Function Key to Understanding Rheumatoid Arthritis

News, rheumatoid arthritis

The discovery of a new pathway involved in immunity may help alleviate rheumatoid arthritis and other inflammatory diseases. A group of researchers from University of Birmingham led by Professor Ed ... Read more

April 3, 2015April 3, 2015

Rheumatoid Arthritis Cited Among Causes of Fatigue

News, rheumatoid arthritis

If you feel fatigued and have rheumatoid arthritis, a number of other factors may also be contributing to your constant feeling of tiredness. A cross-sectional study conducted by the research ... Read more

April 2, 2015April 2, 2015

Rheumatoid Arthritis Drug Prevents Post-Traumatic Osteoarthritis in Mice

News, rheumatoid arthritis

Although rheumatoid arthritis and osteoarthritis are two very unique and separate diseases, a team of researchers at Duke Medicine discovered that a rheumatoid arthritis drug can limit the development of ... Read more